Speaker Profile
CEO, GA4GH
Biography
Peter Goodhand is a senior executive and board member in the global health sector. He has been the senior executive of GA4GH since its founding in 2013. Prior to GA4GH, he was the President and Chief Executive Officer of the Canadian CancerSociety and has also served as the President of the Ontario Institute for Cancer Research. Before joining the notforprofit sector, Goodhand had a 20 year career in the global medical technology industry, including strategic leadership roles with multinational healthcare companies; Board Chair and President of Canada's Medical Device Industry association (MEDTECH); and as the founding Managing Director and the Board Chair of the Health Technology Exchange(HTX).Goodhand is currently CoChair on the boards of Global Genes and the Global Genomic Medicine Collaborative (GGMC); CoChair of the International 100K+ Cohorts Consortium (IHCC); and a member of numerous international advisory boards.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Gad Getz, Broad Institute
- PMWC 2025 Luminary Award
Luminary Honoree: Jensen Huang, Nvidia
- Continued Jensen Huang, Nvidia
- Predictive Modeling for Drug Development
- Luca Emili, InSilicoTrials
- Knowledge Graphs, LLMs & Foundation Models for Enhanced Drug Development
- Janusz Dutkowski, Data4Cure
- Paul Rejto, Pfizer
- PMWC Showcase
- Peter Ellman, Certis Oncology
- Beyond LLMs: Harnessing Advanced AI Models for Genomics and Transcriptomics (PANEL)
Chair: Gad Getz, Broad Institute
- Yasin Şenbabaoğlu, CZ Biohub San Francisco
- Orly Alter, PrismAI
- Nicolo Fusi, Microsoft - Empowering AI in Precision Medicine with Federated Data Platforms
- Noah Nasser, Datma
- Advancing Global Health through Data Sharing: Practical Strategies and Success Stories (PANEL)
Chair: Luca Foschinii, Sage Bionetworks
- Peter Goodhand, GA4GH
- Karen Miga, UCSC
- Philip Awadalla, Ontario Institute for Cancer Research
- Driving Drug Discovery With Low-cost Foundational Omics Datasets
- Gilad Almogy, Ultima Genomics
- Johnny Yu, Vevo Therapeutics
- Stacie Calad-Thomson, NVDIA - Enabling Targeted Precision Drug & Gene Delivery with Predictive AI
- Andre Watson, Ligandal Inc.
- Quantum Leap: The Future of AI and Machine Learning with Quantum Computing
- Matthias Troyer, Microsoft
